One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

Condition(s) studied

Study summary

Many of the patients hospitalized for a severe form of SARSCoV-2 respiratory impairment require prolonged intensive care that can be complicated in the short term, In the medium and long term, physical and psychological sequelae can affect patients' quality of life and prevent a return to normal working life.

To date, there is little data on the fate of patients treated in Resuscitation for a severe form of COVID-19, both in terms of respiratory sequelae, as well as in terms of psychological sequelae and their quality of life. The objective of this study is to be able to describe and evaluate the possible physical and psychological sequelae and quality of life of patients hospitalized in Resuscitation for a severe form of COVID-19 in the short (3 and 6 months), medium (1 year) and long (5 years) End of their stay in ICU. To do this, we want to carry out a prospective, observational and monocentric study in the consultation department of the Nice CHU. All patients admitted to Resuscitation for a severe form of COVID-19 who have accepted the longitudinal medical follow-up proposed by the Nice CHU will be included in the study and data from the computerized medical record will be analyzed.

Eligibility

Primary outcome measure(s)

• Quality of life assessment at 3 months of stay in ICU patients hospitalized for a severe form of COVID-19 — 5 years
  SF-36 score calculation at 3 months of inpatient ICU stay for severe COVID-19

Trial sites (1)

More Centre Hospitalier Universitaire de Nice trials in France

Other trials for the same condition